New COVID-19 Variant PJ.2.1 Detected In THESE Countries; Check Symptoms & Risks
A new COVID-19 variant, PJ.2.1, has been identified across multiple continents since May 2026. While it shows increased binding affinity to human cells, health officials report no unique symptoms or increased severity compared to previous strains.
Why it matters
Ongoing monitoring of viral mutations is critical for public health preparedness and vaccine efficacy updates.
A new COVID-19 variant called PJ.2.1 has been identified and is spreading in several countries, including Canada, the United States, parts of Europe, Asia and Australia. It was first detected in May 2026 and is now being tracked globally. Keep reading to know what makes this variant different, its symptoms, risks and more.
What Makes The New COVID-19 Variant PJ.2.1 Different?
A newly identified COVID-19 variant, PJ.2.1, has drawn global concern following its rapid spread across multiple countries. According to News18, it was first detected in Ontario, Canada, on May 2, 2026. Since then, it has also been identified in the United States, Spain, France, Singapore, Australia, New Zealand and Israel.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in